ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,180.84
0.27%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Marker Therapeutics Inc (MRKR) Share Price

MRKR Marker Therapeutics Inc

4.1647
0.1447 (3.60%)
15 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Marker Therapeutics Inc NASDAQ:MRKR NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.1447 3.60 4.1647 3.90 6.96 4.2399 4.0199 4.02 3,146 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 3.31M -8.24M -0.9266 -4.49 36.98M
 Type  Size  Price  Time  Units 
 13 12 4.10 20:00:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore MRKR News
12/06/202421:05EDGAR2Form 8-K - Current report
17/05/202423:25EDGAR2Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
15/05/202421:40EDGAR2Form 8-K - Current report
15/05/202421:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/04/202412:00GLOBEPrincipal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies 
25/03/202421:45GLOBEMarker Therapeutics Reports Year-End 2023 Corporate and Financial Results
22/03/202416:30GLOBEMarker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Period
Draw mode
Data Downloads for MRKR

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Marker Therapeutics Inc Articles